Pure Autonomic Failure: all 56 studies
Page 1 of 1. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's DiseaseRecruitingNCT06920134Not applicable
- Prodromal Model of Parkinson's Disease Confined to The Peripheral Nervous SystemEnrolling by invitationNCT06745011
- CO2 Rebreathing in nOH: A Proof-of-Concept Pilot StudyRecruitingNCT05908760Not applicable
- CPAP for the Treatment of Supine HypertensionRecruitingNCT05489575Not applicable
- Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension SymptomsRecruitingNCT04782830Not applicable
- Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic FailureRecruitingNCT04502225Not applicable
- [18F]F-DOPA Imaging in Patients With Autonomic FailureRecruitingNCT04246437Phase 1
- Treatment of Supine Hypertension in Autonomic Failure (CPAP)RecruitingNCT03312556Not applicable
- Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine HypertensionRecruitingNCT03042988Not applicable
- Natural History Study of SynucleinopathiesRecruitingNCT01799915
- A Study of Lu AF82422 in Participants With Multiple System AtrophyActive, not recruitingNCT05104476Phase 2Results posted
- Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure PatientsCompletedNCT04620382Early Phase 1Results posted
- Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic FailureTerminatedNCT04095793Phase 3Results posted
- Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic FailureTerminatedNCT03829657Phase 3Results posted
- Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic FailureCompletedNCT03750552Phase 3Results posted
- Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)CompletedNCT02784535Phase 2Results posted
- TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)CompletedNCT02705755Phase 2Results posted
- Local Heat Stress in Autonomic Failure Patients With Supine HypertensionCompletedNCT02417415Not applicableResults posted
- A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa TherapyTerminatedNCT01927055Phase 3Results posted
- Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)CompletedNCT01132326Phase 3Results posted
- Nebivolol in the Supine Hypertension of Autonomic FailureCompletedNCT01044693Not applicableResults posted
- A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using DroxidopaCompletedNCT00782340Phase 3Results posted
- Mechanisms of Hypoglycemia Associated Autonomic FailureTerminatedNCT00678145Phase 2Results posted
- Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)CompletedNCT00633880Phase 3Results posted
- Nitric Oxide and the Autonomic Nervous SystemCompletedNCT00178919Not applicableResults posted
- Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB)CompletedNCT04875949Not applicable
- Synuclein-One StudyCompletedNCT04700722
- Improved Orthostatic Tolerance = Better Cognitive Function in Parkinson's DiseaseCompletedNCT03900000Not applicable
- Concentration and Attentional Deficits in POTS and Other Autonomic NeuropathiesCompletedNCT03681080Not applicable
- Clinical Laboratory Evaluation of Chronic Autonomic FailureCompletedNCT03648905
- Deep Brain Stimulation for Autonomic and Gait Symptoms in Multiple System AtrophyCompletedNCT03593512Not applicable
- Automated Abdominal Binder for Orthostatic HypotensionCompletedNCT03482297Phase 1/2
- Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic FailureTerminatedNCT02897063Phase 1
- Retinal Abnormalities as Biomarker of Disease Progression and Early Diagnosis of Parkinson DiseaseCompletedNCT02640339
- Blood Pressure Lowering Effects of Angiotensin-(1-7) in Primary Autonomic FailureTerminatedNCT02591173Early Phase 1
- Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT02429557Phase 1
- Water and Sudafed in Autonomic FailureTerminatedNCT02149901Early Phase 1
- Physiopathological Study of Autonomic Failure in Parkinson's DiseaseCompletedNCT01748409Not applicable
- Magnetic Resonance Spectroscopy in Autonomic FailureTerminatedNCT01607268
- Norepinephrine Transporter Blockade as a Pathological Biomarker in Neurogenic Orthostatic HypotensionCompletedNCT01316666
- Contribution of Angiotensin II to Supine Hypertension in Autonomic FailureTerminatedNCT01292694Phase 1
- Abdominal Compression in Orthostatic HypotensionCompletedNCT01223391Not applicable
- The Role of Endothelin in the Supine Hypertension of Autonomic FailureWithdrawnNCT01119417Phase 1
- Biomarkers of Risk of Parkinson DiseaseCompletedNCT00775853
- Autonomic Failure Patients for RNA Blood SamplingCompletedNCT00742586
- Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q4WithdrawnNCT00608816Not applicable
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes MellitusWithdrawnNCT00608101Not applicable
- Hypoglycemia Associated Autonomic Failure in Type 1 Diabetes MellitusCompletedNCT00607646Early Phase 1
- Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q5WithdrawnNCT00605774Not applicable
- Hypoglycemia Associated Autonomic Failure in Type 1 DMCompletedNCT00592670Not applicable
- Hypoglycemia Associated Autonomic Failure in Type 1 DM, Q2CompletedNCT00592332Not applicable
- Plasma Exchange for Autoimmune Autonomic FailureCompletedNCT00359346
- Treatment of Supine Hypertension in Autonomic FailureCompletedNCT00223717Phase 1
- Treatment of Orthostatic Hypotension in Autonomic FailureCompletedNCT00223691Phase 1
- The Autonomic Nervous System and ObesityCompletedNCT00179023Phase 1
- Evaluation of Primary Chronic Autonomic FailureTerminatedNCT00059033